GlassScriptPhysician profile
John J Griswold
NPI 1720045941
$3,575.87
in general payments reported to CMS, 2019-2025
28 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $579 · 2021: $679 · 2022: $478 · 2023: $568 · 2024: $323 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $504.36 | 2020-2025 | |
| Endo Pharmaceuticals INC. | $482.33 | 2019-2024 | Xiaflex, Aveed, Edex |
| Neotract INC. | $438.75 | 2019-2020 | |
| Teleflex LLC | $360.76 | 2021-2025 | Urolift |
| Janssen Biotech, INC. | $274.09 | 2022-2023 | Erleada |
| Astellas Pharma US INC | $257.35 | 2019-2025 | Xtandi |
| Urovant Sciences INC | $198.84 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $197.01 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $144.65 | 2023-2025 | Orgovyx, Gemtesa |
| Endo USA, INC. | $81.70 | 2024-2025 | Xiaflex, Aveed, Edex |
| Olympus America INC. | $76.36 | 2021-2025 | Itind System |
| Accord Healthcare, INC. | $67.96 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $56.28 | 2023-2025 | Pylarify |
| Blue Earth Diagnostics | $53.57 | 2019 | |
| Allergan, INC. | $44.31 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $33.70 | 2019-2020 | |
| Medtronic, INC. | $33.12 | 2021 | |
| Coloplast Corp | $32.44 | 2019 | |
| Axonics, INC. | $32.12 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $28.13 | 2019-2020 | |
| Clarus Therapeutics INC. | $27.89 | 2021 | |
| Laborie Medical Technologies Corp. | $25.88 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $24.73 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.15 | 2019 | |
| Dentsply Ih Ab | $22.21 | 2025 | Lofric |
| Procept Biorobotics Corporation | $20.30 | 2023 | Aquabeam Robotic System |
| C. R. Bard, INC. & Subsidiaries | $18.67 | 2023 | Bard Urinary Drainage Bag |
| Pfizer INC. | $15.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Griswold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.